Groove Biopharma Receives $8,000,000 Series B Financing

  • Feed Type
  • Date
    12/12/2011
  • Company Name
    Groove Biopharma
  • Mailing Address
    161 Eastlake Avenue E. Seattle, WA 98102
  • Company Description
    Groove Biopharma focuses on the generation of novel microRNA (miRNA) therapeutics with improved properties, including higher potency and enhanced pharmacodynamic activity. Endogenous microRNAs (miRNAs) are involved in extensive regulatory networks for many target genes and pathways.
  • Website
    http://www.groovebiopharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $8,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The money is expected to run through the end of 2012, as Groove looks to select its lead drug candidates that it believes can make it through the final preclinical studies needed before the FDA will allow clinical trials to begin.
  • M&A Terms
  • Venture Investor
    Alexandria Real Estate Equities
  • Venture Investor
    ARCH Venture Partners
  • Venture Investor
    OVP Venture Partners
  • Venture Investor
    Versant Ventures
  • Venture Investor
    WRF Capital

By posting a comment, you agree to our terms and conditions.